首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi 基因療法

市場調查報告書

商品編碼

1469825

全球病毒清除服務市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Viral Clearance Service Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球病毒清除服務市場的市場規模將從 2023 年的 8.5809 億美元達到近 30.3049 億美元，2024-2032 年研究期間複合年成長率為 15.05%。

病毒清除服務是指生物製藥公司透過去除或去活化病毒和其他潛在污染物來確保生物製品安全的過程。該服務涉及嚴格的測試和驗證程序，以證明層析、過濾和去活化技術等病毒清除方法的有效性。病毒清除服務對於開發和製造生物製劑、疫苗和基因治療產品以降低病毒傳播給患者的風險至關重要。

市場動態

病毒感染、疫情和新出現的病原體的日益流行，加上對生物製藥產品（包括單株抗體、單株和重組蛋白）的需求不斷成長，更加需要強力的病毒清除驗證研究，以確保生物製藥產品的安全性和有效性。病毒清除服務透過評估製造過程中病毒去活化和去除步驟的有效性，在評估生物製劑的病毒安全性方面發揮關鍵作用，推動其在生物製藥行業的採用。此外，歐洲藥品管理局（EMA）和美國食品藥物管理局（FDA）等衛生當局發布的嚴格監管要求和指南要求實施病毒清除研究，作為生物製藥產品法規核准流程的一部分，推動了市場需求。此外，生物製藥生產過程（包括細胞培養、發酵和純化）日益複雜和多樣化，為有效解決病毒污染風險帶來了挑戰，推動了對病毒清除服務提供者提供的專業知識和測試服務的需求，進一步推動了市場成長。

此外，由於資源限制、上市時間壓力以及獨立第三方驗證的需要，生物製藥公司外包病毒清除測試和驗證研究的趨勢不斷成長，為合約研究組織（CRO）和測試實驗室提供全面的病毒清除服務，推動市場擴張。病毒安全法規的不斷發展、分析技術的進步以及生物加工技術的新興趨勢預計將推動市場的進一步創新和投資，支持全球醫療保健市場安全有效的生物製藥產品的開發和商業化。然而，不斷變化的監管要求、技術進步以及來自內部病毒清除能力的競爭可能會挑戰市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球病毒清除服務市場的每個細分市場進行了包容性評估。病毒清除服務產業的成長和趨勢為本研究提供了整體方法。

市場區隔

病毒清除服務市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依方法

病毒清除
病毒去活化（化學、輻射、其他）

按申請

重組蛋白
組織和血液衍生產品
疫苗
其他

按最終用戶

生物製藥
合約研究組織
學術研究機構
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲病毒清除服務市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。病毒清除服務市場的主要參與者包括Texcell、Eurofins Scientific SE、Charles River Laboratories International, Inc.、Merck KGaA、WuXi AppTec、Clean Cells、Vironova Biosafety AB。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：病毒清除服務公司的競爭格局

病毒清除服務市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Texcell

公司簡介
公司收入
產品
最近的發展

Eurofins Scientific SE

公司簡介
公司收入
產品
最近的發展

Charles River Laboratories International Inc.

公司簡介
公司收入
產品
最近的發展

Merck KGaA

公司簡介
公司收入
產品
最近的發展

WuXi AppTec

公司簡介
公司收入
產品
最近的發展

Clean Cells

公司簡介
公司收入
產品
最近的發展

Vironova Biosafety AB

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112114131

The global demand for Viral Clearance Service Market is presumed to reach the market size of nearly USD 3030.49 Million by 2032 from USD 858.09 Million in 2023 with a CAGR of 15.05% under the study period 2024 - 2032.

Viral clearance service refers to a process conducted by biopharmaceutical companies to ensure the safety of biological products by removing or inactivating viruses and other potential contaminants. This service involves rigorous testing and validation procedures to demonstrate the effectiveness of viral clearance methods such as chromatography, filtration, and inactivation techniques. Viral clearance services are critical in developing and manufacturing biologics, vaccines, and gene therapy products to mitigate the risk of viral transmission to patients.

MARKET DYNAMICS

The increasing prevalence of viral infections, outbreaks, and emerging pathogens, coupled with the growing need for biopharmaceutical products, including monoclonal antibodies, monoclonaland recombinant proteins, has heightened the need for robust viral clearance validation research to guarantee the safety and efficacy of biopharmaceutical products for human use. Viral clearance services play a critical role in assessing the viral safety of biologics by evaluating the effectiveness of viral inactivation and removal steps during manufacturing processes, driving their adoption across the biopharmaceutical industry. Additionally, stringent regulatory requirements and guidelines issued by health authorities such as the EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) mandate the implementation of viral clearance studies as part of the regulatory approval process for biopharmaceutical products, driving market demand. Moreover, increasing complexity and diversity in biopharmaceutical production processes, including cell culture, fermentation, and purification, have created challenges in effectively addressing viral contamination risks, driving the need for specialized expertise and testing services offered by viral clearance service providers, further fuelling market growth.

Furthermore, the growing trend towards outsourcing viral clearance testing and validation studies by biopharmaceutical companies, driven by resource constraints, time-to-market pressures, and the need for independent third-party validation, has created opportunities for contract research organizations (CROs) and testing laboratories to offer comprehensive viral clearance services, driving market expansion. The evolving landscape of viral safety regulations, advancements in analytical techniques, and emerging trends in bioprocessing technology are expected to drive further innovation and investment in the market, supporting the development and commercialization of safe and effective biopharmaceutical products for global healthcare markets. However, evolving regulatory requirements, technological advancements, and competition from in-house viral clearance capabilities may challenge the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of viral clearance service. The growth and trends of viral clearance service industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the viral clearance service market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

Viral Removal
Viral Inactivation (Chemical, Radiation, Others)

By Application

Recombinant Proteins
Tissue And Blood-Derived Products
Vaccines
Others

By End-User

Biopharmaceuticals
Contract Research Organizations
Academic Research Institutes
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Viral Clearance Service market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Viral Clearance Service market include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA, WuXi AppTec, Clean Cells, Vironova Biosafety AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . VIRAL CLEARANCE SERVICE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Method
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY METHOD

5.1 Overview by Method
5.2 Historical and Forecast Data
5.3 Analysis by Method
5.4 Viral Removal Historic and Forecast Sales by Regions
5.5 Viral Inactivation (Chemical, Radiation, Others) Historic and Forecast Sales by Regions

6 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Recombinant Proteins Historic and Forecast Sales by Regions
6.5 Tissue and Blood-derived Products Historic and Forecast Sales by Regions
6.6 Vaccines Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Biopharmaceuticals Historic and Forecast Sales by Regions
7.5 Contract Research Organizations Historic and Forecast Sales by Regions
7.6 Academic Research Institutes Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE VIRAL CLEARANCE SERVICE COMPANIES

9.1. Viral Clearance Service Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF VIRAL CLEARANCE SERVICE INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Texcell
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Eurofins Scientific SE
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Charles River Laboratories International Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Merck KGaA
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. WuXi AppTec
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Clean Cells
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Vironova Biosafety AB
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Method (USD MN)
Viral Removal Market Sales by Geography (USD MN)
Viral Inactivation (Chemical, Radiation, Others) Market Sales by Geography (USD MN)
Analysis Market by Application (USD MN)
Recombinant Proteins Market Sales by Geography (USD MN)
Tissue and Blood-derived Products Market Sales by Geography (USD MN)
Vaccines Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis by End-user (USD MN)
Biopharmaceuticals Market Sales by Geography (USD MN)
Contract Research Organizations Market Sales by Geography (USD MN)
Academic Research Institutes Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Viral Clearance Service Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Viral Clearance Service Report
Market Research Process
Market Research Methodology
Global Viral Clearance Service Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Method
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Method (USD MN)
Viral Removal Market Sales by Geography (USD MN)
Viral Inactivation (Chemical, Radiation, Others) Market Sales by Geography (USD MN)
Global Market Analysis by Application (USD MN)
Recombinant Proteins Market Sales by Geography (USD MN)
Tissue and Blood-derived Products Market Sales by Geography (USD MN)
Vaccines Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Biopharmaceuticals Market Sales by Geography (USD MN)
Contract Research Organizations Market Sales by Geography (USD MN)
Academic Research Institutes Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis